Noriyuki Doi
Stories by Noriyuki Doi
Fosun Pharma to sell $124m stake in hospital chain to Warburg
Fosun will transfer its 6.6% ownership in New Frontier Health.
Ant Group splurges nearly $3b on R&D spending in 2023 for AI, Alipay
Ant has been developing a proprietary LLM called the Bailing foundational model.
China’s Fosun looks to shed $3b worth of assets this year as debt burden weighs
Consumer goods and services will form the group's core moving forward.
